Unicycive Therapeutics logo

Unicycive Therapeutics Share Price Today

(NASDAQ: UNCY)

Unicycive Therapeutics share price is $0.56 & ₹48.70 as on 6 Mar 2025, 2.30 'hrs' IST

$0.56

0.04

(8%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Unicycive Therapeutics share price in Dollar and Rupees. Guide to invest in Unicycive Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Unicycive Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Unicycive Therapeutics share price movements

  • Today's Low: $0.50
    Today's High: $0.57

    Day's Volatility :12.09%

  • 52 Weeks Low: $0.20
    52 Weeks High: $1.73

    52 Weeks Volatility :88.32%

Unicycive Therapeutics (UNCY) Returns

PeriodUnicycive Therapeutics IncIndex (Russel 2000)
3 Months
-24.63%
0.0%
6 Months
47.18%
0.0%
1 Year
-66.01%
0.0%
3 Years
-62.32%
-11.6%

Unicycive Therapeutics (UNCY) Key Statistics

in dollars & INR

Previous Close
$0.52
Open
$0.51
Today's High
$0.569
Today's Low
$0.5002
Market Capitalization
$54.0M
Today's Volume
$87.6K
52 Week High
$1.73
52 Week Low
$0.202
Revenue TTM
$0.0
EBITDA
$-29.2M
Earnings Per Share (EPS)
$-0.46
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-147.05%

How to invest in Unicycive Therapeutics Stock (UNCY) from India?

It is very easy for Indian residents to invest directly in Unicycive Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Unicycive Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Unicycive Therapeutics or UNCY on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Unicycive Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Unicycive Therapeutics shares which would translate to 1.553 fractional shares of Unicycive Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Unicycive Therapeutics, in just a few clicks!

Returns in Unicycive Therapeutics (UNCY) for Indian investors in Rupees

The Unicycive Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Unicycive Therapeutics investment value today

Current value as on today

₹41,564

Returns

₹58,436

(-58.44%)

Returns from Unicycive Therapeutics Stock

₹63,399 (-63.4%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Unicycive Therapeutics (UNCY)

-31.01%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Investment in Unicycive Therapeutics Shares from India has dropped by -31.01% over the past 30 days, indicating reduced transactional activity.

-21%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Unicycive Therapeutics Stock from India on INDmoney has decreased by -21% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Unicycive Therapeutics

  • Great Point Partners LLC

    10.58%

  • Nantahala Capital Management, LLC

    10.01%

  • Octagon Capital Advisors LP

    9.63%

  • Vivo Capital, LLC

    9.61%

  • Logos Global Management LP

    4.89%

  • Walleye Trading Advisors, LLC

    4.82%

Analyst Recommendation on Unicycive Therapeutics

Buy

    90%Buy

    9%Hold

    0%Sell

Based on 11 Wall street analysts offering stock ratings for Unicycive Therapeutics(by analysts ranked 0 to 5 stars)

Based on 11 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
10
9
8
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Unicycive Therapeutics Stock (UNCY)

What analysts predicted

Upside of 882.14%

Target:

$5.50

Current:

$0.56

Insights on Unicycive Therapeutics Stock (Ticker Symbol: UNCY)

  • Price Movement

    In the last 6 months, UNCY stock has moved up by 47.2%
  • Decreasing Revenue

    Revenue is down for the last 3 quarters, 951.0K → -271.0K (in $), with an average decrease of 84.6% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, 3.93M → -4.09M (in $), with an average decrease of 204.2% per quarter
  • UNCY vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 126.9%
  • UNCY vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 47.7% return, outperforming this stock by 111.6%

Unicycive Therapeutics Technicals Summary

Sell

Neutral

Buy

Unicycive Therapeutics is currently in a neutral trading position according to technical analysis indicators.

Unicycive Therapeutics (UNCY) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Unicycive Therapeutics Inc logo
-13.33%
47.18%
-66.01%
-62.32%
-91.11%
Regeneron Pharmaceuticals, Inc. logo
1.3%
-41.29%
-30.51%
9.2%
42.38%
Beone Medicines Ltd logo
15.19%
34.31%
61.3%
43.16%
68.1%
Vertex Pharmaceuticals Incorporated logo
3.37%
3.77%
18.06%
106.43%
121.36%
Alnylam Pharmaceuticals, Inc. logo
-11.52%
-3.4%
62.32%
49.04%
120.93%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Unicycive Therapeutics Inc logo
NA
NA
NA
-0.53
-1.47
-0.63
NA
0.28
Regeneron Pharmaceuticals, Inc. logo
17.85
17.85
1.03
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.33
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Unicycive Therapeutics Inc logo
Buy
$54.0M
-91.11%
NA
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$74.9B
42.38%
17.85
31.07%
Beone Medicines Ltd logo
NA
$28.5B
68.1%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.1B
121.36%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.5B
120.93%
NA
-12.37%

About Unicycive Therapeutics

Unicycive Therapeutics, Inc., a biotechnology company, develops treatments for various medical conditions in the United States. Its drug candidates include UNI 494, a pro-drug of Nicorandil that is being developed as a treatment for acute kidney injury; and Renazorb (Oxylanthanum Carbonate), which is being developed for the treatment of hyperphosphatemia in patients with chronic kidney disease. Unicycive Therapeutics, Inc. has license agreements with Shilpa Medicare Ltd; Sphaera Pharma Pte. Ltd.; Syneos Health LLC; Inotiv; Lee's Pharmaceutical (HK) Limited; Celerion; and Lotus International Pte Ltd. The company was incorporated in 2016 and is based in Los Altos, California.
Organization
Unicycive Therapeutics
Employees
14
CEO
Dr. Shalabh K. Gupta M.D., MPA
Industry
Miscellaneous

Management People of Unicycive Therapeutics

NameTitle
Dr. Shalabh K. Gupta M.D., MPA
Founder, Chairman, CEO & President
Dr. Pramod Gupta Ph.D.
Executive Vice President of Pharmaceutical & Business Operations
Mr. Douglas Jermasek M.B.A.
Executive Vice President of Corporate Strategy
Mr. John W. Townsend CPA
Chief Financial Officer

Important FAQs about investing in UNCY Stock from India :

What is Unicycive Therapeutics share price today?

Unicycive Therapeutics share price today stands at $0.56, Open: $0.51 ; Previous Close: $0.52 ; High: $0.57 ; Low: $0.50 ; 52 Week High: $1.73 ; 52 Week Low: $0.20.

The stock opens at $0.51, after a previous close of $0.52. The stock reached a daily high of $0.57 and a low of $0.50, with a 52-week high of $1.73 and a 52-week low of $0.20.

Can Indians buy Unicycive Therapeutics shares?

Yes, Indians can invest in the Unicycive Therapeutics (UNCY) from India.

With INDmoney, you can buy Unicycive Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Unicycive Therapeutics at zero transaction cost.

How can I buy Unicycive Therapeutics shares from India?

It is very easy to buy Unicycive Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Unicycive Therapeutics (UNCY) be purchased?

Yes, you can buy fractional shares of Unicycive Therapeutics with INDmoney app.

What are the documents required to start investing in Unicycive Therapeutics stocks?

To start investing in Unicycive Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Unicycive Therapeutics Stock (UNCY)?

Today’s highest price of Unicycive Therapeutics (UNCY) is $0.57.

Today’s lowest price of Unicycive Therapeutics (UNCY) is $0.50.

What is today's market capitalisation of Unicycive Therapeutics?

Today's market capitalisation of Unicycive Therapeutics UNCY is 54.0M

What is the 52 Week High and Low Range of Unicycive Therapeutics Stock (UNCY)?

  • 52 Week High

    $1.73

  • 52 Week Low

    $0.20

What are the historical returns of Unicycive Therapeutics (UNCY)?

  • 1 Month Returns

    -13.33%

  • 3 Months Returns

    47.18%

  • 1 Year Returns

    -66.01%

  • 5 Years Returns

    -91.11%

Who is the Chief Executive Officer (CEO) of Unicycive Therapeutics ?

Dr. Shalabh K. Gupta M.D., MPA is the current Chief Executive Officer (CEO) of Unicycive Therapeutics.